Four Impact Companies to Pitch Live on National Television Event

The Superpowers for Good Live Pitch event on March 17 will feature four mission-driven companies presenting their investment opportunities during a two-hour televised broadcast designed to engage viewers in real time. My Diabetes Health, rHEALTH, GigaWatt, and BRG Therapeutics will pitch their approaches to health and sustainability challenges, with television viewers invited to submit questions for founders and vote live for the SuperCrowd Award winner. Léa Bouhelier-Gautreau, a Senior Investment Associate in Impact Investing at KingsCrowd, noted that these companies demonstrate the breadth of the impact category, spanning preventive health, diagnostics, energy infrastructure, and early-stage therapeutics.

The event format emphasizes direct engagement between entrepreneurs and potential investors, with Sherwood Neiss of Crowdfund Capital Advisors explaining that live questioning creates a more authentic investment environment where companies must explain their evidence, plans, and risks transparently. Paul Lovejoy of Stakeholder Enterprise added that audience participation elevates the conversation by surfacing core questions about traction, validation, economics, and execution in real time for all viewers. Registration for the private investor session following the broadcast is free at https://thesupercrowd.com/26q1pitch.

My Diabetes Health focuses on insurance-covered telehealth diabetes education, reporting that 8,600 patients using its program have achieved an average 1.6-point A1C improvement. The company's pitch will emphasize how accessible education can function as a scalable intervention for diabetes management. rHEALTH is developing a space-validated blood diagnostics platform intended for consumer and point-of-care use, with development work connected to NASA and NIH. The company's presentation will focus on speed, accessibility, and the practical value of diagnostics that can be deployed where people receive care.

GigaWatt positions itself as an established business working to scale distributed energy solutions, having generated more than $54 million in revenue since 2019 and earned a 4.7 collective rating across 1,300 verified Google reviews. The company's pitch will connect its operating track record to the accelerating shift toward electrification, solar, storage, and smarter energy management. BRG Therapeutics is developing novel anticancer and antiviral therapeutics with a dual-action approach across two high-need therapeutic areas, with its pitch expected to outline a development plan focused on research milestones and preclinical work.

The March 17 broadcast will air live on Roku and Amazon Fire TV via the e360tv Network, with additional distribution via social channels. During the event, television viewers can submit questions that will be asked on-air, giving the public a chance to hear founders respond in real time. Viewers will also vote live for the SuperCrowd Award winner, while a three-judge panel selects a separate judges' choice. The production will host a private investor session via Zoom immediately following the broadcast, where interested viewers can engage founders with deeper questions. Registration for the investor session is available at https://thesupercrowd.com/26q1pitch.